top646 download apk latest version
Kohl's CEO Kingsbury to step downQB Josh Allen and coach Sean McDermott deserve credit in Bills latest AFC East-clinching seasonRescuers reassess safety in search for woman they think fell into a Pennsylvania sinkhole
Enron , once among the largest energy companies in the U.S., has become a punchline since it famously collapsed amid inflated profits and corporate fraud in 2001. Now, social media posts, a slick promotional video and a revamped website suggest the infamous company is making a comeback. On Dec. 2, it posted promotional videos on TikTok , BlueSky and X about adapting to the changing world featuring inspiring imagery and diverse voices claiming "I am Enron" with the tagline, “We're back. Can we talk?” To coincide with the video and website launch, cryptocurrency bloggers speculated Enron will be involved in cryptocurrency exchange. Others speculated the rebranding is fake or parody . THE SOURCES Enron.com terms of use page Will Chabot , managing director of media strategy for Stu Loeser & Co. Enron Corporation articles of incorporation United States Patent and Trademark Office Wayback Machine archives of Enron.com WHAT WE FOUND On Dec. 2, a company calling itself Enron Corporation published a promotional video on social media, introduced a new website and issued a press release announcing a relaunch of the company. But the relaunched website calls itself a parody. The new company with the infamous name is owned by Connor Gaydos, the co-founder of satirical conspiracy group “Birds Aren’t Real.” A disclaimer on the website’s terms of service page reads, “THE INFORMATION ON THE WEBSITE IS FIRST AMENDMENT PROTECTED PARODY, REPRESENTS PERFORMANCE ART, AND IS FOR ENTERTAINMENT PURPOSES ONLY.” VERIFY reached out to the media contact listed on Enron’s website and in the press release about the site’s relaunch. Will Chabot , spokesperson for the current Enron brand and managing director of media strategy for Stu Loeser & Co., would not confirm or deny if the company was real or parody, but did direct VERIFY to the company’s articles of incorporation and press release about the relaunch. “I understand you had some questions about Enron's launch. While I'm not able to answer all of them (we'll have more to share soon - including a big announcement in the energy space - and will be sure to keep you in the loop),” Chabot told VERIFY. The latest iteration of Enron Corporation’s articles of incorporation were filed in Delaware on Feb. 28, 2024 by Gaydos, according to records provided to VERIFY by Chabot. Gaydos is the co-founder of Birds Aren’t Real , a satirical conspiracy group founded in 2017 that jokingly claims the U.S. government has been replacing living birds with surveillance drones. Gaydos registered the Enron trademark on May 13, 2020, through his The College Company LLC, which also has registered trademarks for Birds Aren’t Real. According to the trademark application for Enron, the trademark is used for shirts and other merchandise. The new website has merchandise for sale. Archival versions of Enron.com dating back to 1998 are available on The Wayback Machine. In January of 2024, the website domain of enron.com was available for purchase , archives of the page show. The last time that URL represented the bankrupt energy giant was in 2007 . There is no evidence to support claims the Enron brand was relaunched as a cryptocurrency firm, as some have speculated. There is a page on Enron’s new website titled “decentralization,” which is a common term to describe the kind of technology behind cryptocurrency. The website says, “Decentralized technology is advancing, and we will of course have a role to play in its future. We couldn't be more excited to show you, but until then please stay vigilant and avoid falling for scams. When we announce something, you'll know.” Related Articles Watch out for these common holiday scams Yes, you can still fly Spirit after it filed for bankruptcy 5 tips to avoid online shopping scams: VERIFY Fact Sheet The VERIFY team works to separate fact from fiction so that you can understand what is true and false. Please consider subscribing to our daily newsletter , text alerts and our YouTube channel . You can also follow us on Snapchat , Instagram , Facebook and TikTok . Learn More » Follow Us YouTube Snapchat Instagram Facebook TikTok Want something VERIFIED? Text: 202-410-8808
'Going to come after you': Inside Kash Patel's 'lawfare' suit against ex-Pence officialWoolies goes to Fair Work to bust worker blockade
Golden at-bat idea brings critics to the plate: 'Absolutely stupid and ridiculous'Health Initiative Reveals Alarming Hypertension Rates Among Mallam Market Traders
TimesLIVE
Percentages: FG .444, FT .708. 3-Point Goals: 8-22, .364 (Nwokeji 3-6, McCray 2-5, Arias 1-2, K.Jackson 1-2, Bell 1-5, Munson 0-1, Spence 0-1). Team Rebounds: 2. Team Turnovers: 1. Blocked Shots: 4 (Rivers 2, Nwokeji, Payne). Turnovers: 15 (McCray 5, Arias 2, Payne 2, Spence 2, Bell, Borio, K.Jackson, Nwokeji). Steals: 13 (Bell 2, McCray 2, Munson 2, Payne 2, Rivers 2, Spence 2, Arias). Technical Fouls: None. Percentages: FG .581, FT .688. 3-Point Goals: 7-21, .333 (Robinson 4-5, Shoulders 2-4, Bryant 1-4, Vaistaras 0-1, Grant 0-3, Johnson 0-4). Team Rebounds: 2. Team Turnovers: None. Blocked Shots: 4 (Holt, Johnson, Overstreet, Robinson). Turnovers: 18 (Robinson 10, Holt 2, Johnson 2, Bryant, Grant, Montas, Shoulders). Steals: 10 (Robinson 3, Johnson 2, Shoulders 2, Bryant, Holt, Overstreet). Technical Fouls: None. A_592 (3,300).NoneIt looked like a recipe for disaster. So, when his country's swimmers were being accused of doping earlier this year, one Chinese official cooked up something fast. He blamed it on contaminated noodles. In fact, he argued, it could have been a culinary conspiracy concocted by criminals, whose actions led to the cooking wine used to prepare the noodles being laced with a banned heart drug that found its way into an athlete's system. This theory was spelled out to international anti-doping officials during a meeting and, after weeks of wrangling, finally made it into the thousands of pages of data handed over to the lawyer who investigated the case involving 23 Chinese swimmers who had tested positive for that same drug. The attorney, appointed by the World Anti-Doping Agency, refused to consider that scenario as he sifted through the evidence. In spelling out his reasoning, lawyer Eric Cottier paid heed to the half-baked nature of the theory. "The Investigator considers this scenario, which he has described in the conditional tense, to be possible, no less, no more," Cottier wrote. Even without the contaminated-noodles theory, Cottier found problems with the way WADA and the Chinese handled the case but ultimately determined WADA had acted reasonably in not appealing China's conclusion that its athletes had been inadvertently contaminated. Critics of the way the China case was handled can't help but wonder if a wider exploration of the noodle theory, details of which were discovered by The Associated Press via notes and emails from after the meeting where it was delivered, might have lent a different flavor to Cottier's conclusions. "There are more story twists to the ways the Chinese explain the TMZ case than a James Bond movie," said Rob Koehler, the director general of the advocacy group Global Athlete. "And all of it is complete fiction." In April, reporting from the New York Times and the German broadcaster ARD revealed that the 23 Chinese swimmers had tested positive for the banned heart medication trimetazidine, also known as TMZ. China's anti-doping agency determined the athletes had been contaminated, and so, did not sanction them. WADA accepted that explanation, did not press the case further, and China was never made to deliver a public notice about the "no-fault findings," as is often seen in similar cases. The stock explanation for the contamination was that traces of TMZ were found in the kitchen of a hotel where the swimmers were staying. In his 58-page report, Cottier relayed some suspicions about the feasibility of that chain of events — noting that WADA's chief scientist "saw no other solution than to accept it, even if he continued to have doubts about the reality of contamination as described by the Chinese authorities." But without evidence to support pursuing the case, and with the chance of winning an appeal at almost nil, Cottier determined WADA's "decision not to appeal appears indisputably reasonable." A mystery remained: How did those traces of TMZ get into the kitchen? Shortly after the doping positives were revealed, the Institute of National Anti-Doping Organizations held a meeting on April 30 where it heard from the leader of China's agency, Li Zhiquan. Li's presentation was mostly filled with the same talking points that have been delivered throughout the saga — that the positive tests resulted from contamination from the kitchen. But he expanded on one way the kitchen might have become contaminated, harkening to another case in China involving a low-level TMZ positive. A pharmaceutical factory, he explained, had used industrial alcohol in the distillation process for producing TMZ. The industrial alcohol laced with the drug "then entered the market through illegal channels," he said. The alcohol "was re-used by the perpetrators to process and produce cooking wine, which is an important seasoning used locally to make beef noodles," Li said. "The contaminated beef noodles were consumed by that athlete, resulting in an extremely low concentration of TMZ in the positive sample. "The wrongdoers involved have been brought to justice." This new information raised eyebrows among the anti-doping leaders listening to Li's report. So much so that over the next month, several emails ensued to make sure the details about the noodles and wine made their way to WADA lawyers, who could then pass it onto Cottier. Eventually, Li did pass on the information to WADA general counsel Ross Wenzel and, just to be sure, one of the anti-doping leaders forwarded it, as well, according to the emails seen by the AP. All this came with Li's request that the noodles story be kept confidential. Turns out, it made it into Cottier's report, though he took the information with a grain of salt. "Indeed, giving it more attention would have required it to be documented, then scientifically verified and validated," he wrote. Neither Wenzel nor officials at the Chinese anti-doping agency returned messages from AP asking about the noodles conspiracy and the other athlete who Li suggested had been contaminated by them. Meanwhile, 11 of the swimmers who originally tested positive competed at the Paris Games earlier this year in a meet held under the cloud of the Chinese doping case. Though WADA considers the case closed, Koehler and others point to situations like this as one of many reasons that an investigation by someone other than Cottier, who was hired by WADA, is still needed. "It gives the appearance that people are just making things up as they go along on this, and hoping the story just goes away," Koehler said. "Which clearly it has not." Get local news delivered to your inbox!
Michigan aims to cap lost season by beating Ohio State
Industrial Boilers Market Size, Share, Trends, Competitive Landscape, Regional Analysis Forecasts with a CAGR of 3.3% By 2030 12-20-2024 07:48 PM CET | Business, Economy, Finances, Banking & Insurance Press release from: ABNewswire The global market size of industrial boilers is projected to grow from USD 15.3 billion in 2022 to USD 19.8 billion by 2030, at a CAGR of 3.3% during the forecast period. The industrial boilers market is poised for steady growth, driven by rising demand for energy-efficient solutions across industries. Advancements in technology, coupled with stringent environmental regulations, are expected to shape market trends, fostering innovations and expanding global market opportunities. The report "Industrial Boilers Market [ https://www.marketsandmarkets.com/Market-Reports/industrial-boiler-market-130210505.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=industrialboiler ] by Fuel (Natural Gas, Coal, Oil), Boiler (Fire-Tube, Water Tube), Function (Hot Water, Steam), Boiler Horsepower (10-150 BHP, 151-300 BHP, 301-600 BHP), End-Use Industry, And Region - Global Forecast to 2030 ", MarketsandMarkets: The global market size of industrial boilers is projected to grow from USD 15.3 billion in 2022 to USD 19.8 billion by 2030, at a CAGR of 3.3% during the forecast period. Stringent government regulations to minimize carbon emissions and maximize renewable energy usage, increase power and food industry demand, and use clean technology in the chemical end-use industry drive the industrial boilers market. Browse 249 market data Tables and 55 Figures spread through 239 Pages and in-depth TOC on "Industrial Boilers Market by Fuel (Natural Gas, Coal, Oil), Boiler (Fire-Tube, Water Tube), Function (Hot Water, Steam), Boiler Horsepower (10-150 BHP, 151-300 BHP, 301-600 BHP), End-Use Industry, And Region - Global Forecast to 2030" Get PDF Brochure for Research Insights at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130210505 [ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130210505&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=industrialboiler ] The food and beverage industry requires a large amount of steam and hot water for various processes such as steam generation, heating & drying, and sanitation. Boilers are used in this industry to generate steam for various applications, such as cooking, cleaning, and sterilization. Moreover, the increasing population, rising disposable income, and changing dietary habits fuel the demand for processed food and beverages, leading to the expansion of food and beverage facilities in different regions. This expansion of the facilities increases the demand for heat and power in the food and beverage industry, resulting in high demand for industrial boilers. In terms of value, fire-tube boilers are estimated to be the largest market in the global industrial boilers market, by boiler type, during the forecast period. Fire-tube boilers are also referred to as shell & tube boilers or smoke tube boilers. Fire-tube boilers are usually preferred for industrial purpose as these boilers are fuel-efficient & and easy to operate. However, other boilers such as Fluidized bed combustion boilers are gaining traction in the market. It has emerged as a viable alternative and has significant advantages over conventional firing systems and offers multiple benefits, including compact boiler design, fuel flexibility, higher combustion efficiency and reduced emission of toxic pollutants such as SOx and NOx. Natural gas to be the largest market in the global industrial boilers market, by fuel type, during 2022 to 2030. Natural gas is the best fuel choice for industrial boiler production and accounted for more than quarter of the total market in 2022. Natural gas can be piped directly into the natural gas-fired boilers. These boilers require a relatively small boiler space with a compact and simple design. Natural gas-fired boilers are widely used in western countries due to their easy availability and regulatory guidelines concerning CO2 emissions. Request for Bundle Report at https://www.marketsandmarkets.com/RequestBundleReport.asp?id=130210505 [ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=130210505&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=industrialboiler ] Steam boilers to be the largest market in the global industrial boilers market, by function type, during 2022 to 2030 The steam boilers segment accounted for more than half of the total market, in terms of value, and is projected to register a CAGR of 3.1%during the forecast period. Steam boilers can be used in power turbines that generate electricity. However, due to the vertical design of the steam boiler, less steam is emitted. Steam boilers are used in various industries, including power, food, and cement. 150-300 BHP boilers are estimated to be the second-largest boiler market, by horsepower type, by value in 2022. The 151-300 BHP boilers segment is expected to be the second fastest-growing segment, at a CAGR of 3.4%, between 2022 and 2030, in terms of value. These boilers are fueled by organic materials such as wood chips, sawdust, and agricultural waste to generate heat and power. 151-300 BHP boilers are preferred for precise pressure and temperature output of steam or water required for processing activities in end-use industries like food and pharmaceuticals. Food is estimated to be the second-largest end-use industry, by value in 2022. Food processing is one of the fastest-growing global industries. According to data published in the economic times, the food & grocery market in India ranks sixth globally, and food processing contributes about 32% to the food industry. Boilers are crucial in the food industry due to the heat generation (direct or from hot water) required in various food processes. The food industry uses coal, natural gas, liquid fuel, and biomass as fuels in boilers. Steam provides precise temperature control through relatively simple, inexpensive pressure control to deliver consistent heat across the largest vessels and offers the precision to ensure that the highest quality food is produced for the manufacturers' end-user consumers. Europe accounted for second largest region, by value, during the forecast period 2022-2030 Europe accounts for a significant share in terms of consumption in the industrial boilers market. Numerous manufacturers, particularly in the chemical and food end-use industries, influence the demand for industrial boilers. Major sales of chemicals in Europe are in terms of petrochemicals and polymers. Germany is the largest producer of chemicals in Europe. The region has witnessed a rise in government initiatives for implementing clean energy in the industrial sector. Industrial boilers are an efficient and clean energy alternative to help address the energy challenges faced by the region. Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=130210505 [ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=130210505&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=industrialboiler ] Babcock & Wilcox Enterprises INC (US), Siemens AG (Germany), John Wood Group PLC (UK), Dongfang Electric Corporation Limited (DEC LTD) (China), Mitsubishi Power (Japan), Thermax Limited (India), Sofinter Group (Italy), Bharat Heavy Electricals Limited (BHEL) (India), Harbin Electric Company Limited (China), IHI Corporation (Japan), Alfa Laval AB (Sweden), Andritz AG (Austria), Robert Bosch GMBH (Germany), Cleaver Brooks Inc. (US), and Byworth Boilers Limited (UK) are the key players in the industrial boilers market. About MarketsandMarkets Trademark MarketsandMarkets Trademark has been recognized as one of America's best management consulting firms by Forbes, as per their recent report. MarketsandMarkets Trademark is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore Trademark (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. Media Contact Company Name: MarketsandMarkets Trademark Research Private Ltd. Contact Person: Mr. Rohan Salgarkar Email:Send Email [ https://www.abnewswire.com/email_contact_us.php?pr=industrial-boilers-market-size-share-trends-competitive-landscape-regional-analysis-forecasts-with-a-cagr-of-33-by-2030 ] Phone: 18886006441 Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 City: Florida State: Florida Country: United States Website: https://www.marketsandmarkets.com/Market-Reports/industrial-boiler-market-130210505.html This release was published on openPR.FIFA signs Netflix to US broadcast deal for the Women’s World Cup in 2027 and 2031
Ant and Dec brought news of a 'shake-up' for I'm A Celebrity Get Me Out of Here at the end of Friday night's show, as some viewers cried 'fix' at the latest result. The Geordie presenters are now nearing the end of their latest stint at the helm of the ITV programme, having fronted it since its inception back in 2002. The competition has been heating up in the jungle over the last week, with Jane Moore, Dean McCullough, Tulisa , Melvin Odoom all kicked out on their own, before Barry McGuigan and Maura Higgins left together in the first of two double eliminations on Thursday. The bad news for the remaining I'm A Celebrity stars in camp was that there was another double exit on Friday, as Coronation Street actor Alan Halsall and social media icon GK Barry were given their marching orders by Ant and Dec. . After interviewing both evicted stars, the hosts had some big announcement for the millions watching at home, revealing that for the first time this series, I'm A Celebrity will be shunted from its usual 9pm primetime slot on ITV, to make way for the reboot of You Bet, hosted by Holly Willoughby and Stephen Mulhern. With another vote-off looming before the final, as well as this year's Celebrity Cyclone, Ant and Dec confirmed that Saturday's I'm A Celebrity will start at the later time of 9.30pm. The announcement came as fans called 'fix' over Oti being given immunity from two separate eliminations, effectively taking the power out of their hands. Taking to X, one critic blasted: "I'm a celeb such a fix! How has oti been allowed to survive last few votes offs" as a second commented: "Oti would have been out by now already if she had not won the golden ticket fix. Other campmates are more popular."QB Josh Allen and coach Sean McDermott deserve credit in Bills latest AFC East-clinching season
TSX Fades at BellNEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited MESO MSB ), global leader in allogeneic cellular medicines for inflammatory diseases, today announced a key publication in the November 2024 online issue of the prestigious peer-reviewed European Journal of Heart Failure (EJHF) , which reports that a single intramyocardial injection of the Company's allogeneic cell therapy Revascor ® (rexlemestrocel-L) results in improved survival in high-risk patients with ischemic heart failure and inflammation. 1 Results from the randomized, controlled DREAM-HF trial in patients with chronic heart failure with reduced ejection fraction (HFrEF) identified the control group at highest risk of cardiovascular death as being those with ischemic etiology and inflammation and showed that a single intramyocardial injection of Mesoblast's mesenchymal precursor cell therapy (MPCs; rexlemestrocel-L) resulted in a sustained reduction in cardiovascular mortality in these high-risk patients. This identifies the target HFrEF population that is responsive to REVASCOR therapy. DREAM-HF's lead investigator, Dr. Emerson C. Perin, MD, PhD, FACC, Medical Director at The Texas Heart Institute, said, "Mesoblast's allogeneic MPCs may restore the balance between anti-inflammatory and pro-inflammatory cytokines in the damaged, inflamed heart. A single administration of MPCs appears sufficient to improve survival and other major clinical outcomes in high-risk HFrEF patients with inflammation. These effects are seen on top of existing treatments that target neurohormonal imbalances and congestion, providing a disease-modifying approach not achievable with standard-of-care alone." The newly published results showed that over a mean follow-up of 30 months in the DREAM-HF trial: Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology (p=0.097), with increased cardiovascular death risk of 61% and 38%, respectively. A single intra-myocardial MPC administration significantly lowered the risk of cardiovascular death in HFrEF patients with inflammation regardless of whether plasma hsCRP or plasma IL-6 was used as inflammatory biomarker by 80% (p=0.003) and 60% (p=0.037) respectively. MPCs reduced 2-point MACE (heart attack or stroke) by 57% (p=0.016) and 3-point MACE (cardiovascular death, heart attack, stroke) by 35% (p=0.049) in patients with ischemic HFrEF (n=303) compared to controls. MPCs reduced 2-point and 3-point MACE by 88% (p=0.005) and 52% (p=0.018) respectively, in patients with ischemic HFrEF and inflammation (n=158) compared to controls. "We are pursuing potential approval pathways for our STRO3-immunoselected and industrially manufactured heart failure product REVASCOR across the continuum from pediatric congenital heart disease to adults with ischemic HFrEF," said Mesoblast Chief Executive Dr. Silviu Itescu. "Earlier this year we received feedback from the U.S. Food and Drug Administration (FDA) providing support for an accelerated approval pathway in end-stage ischemic HFrEF patients with a left ventricular assist device (LVAD). This new publication identifies the larger ischemic HFrEF population which responds to REVASCOR with mortality benefit." About Revascor ® (rexlemestrocel-L) in Heart Disease REVASCOR is an allogeneic preparation of immunoselected and culture-expanded mesenchymal precursor cells (MPC) and is being developed as an immunomodulatory therapy to address the high degree of inflammation in the heart and cardiovascular system that is present across the spectrum of HFrEF patients ranging from New York Heart Association (NYHA) class II through end-stage disease, in order to reduce the high rate of major cardiovascular events and complications. This investigational therapy has been evaluated in two large placebo-controlled randomized studies in patients with chronic HFrEF. These consisted of a trial with 537 NYHA class II/III treated patients (DREAM-HF) 2 and a 159-patient trial in end-stage HFrEF patients implanted with a left ventricular assist device (LVAD). Rexlemestrocel-L has US Food and Drug Administration (FDA) Regenerative Medicine Advanced Therapy (RMAT) and Orphan Drug designations for patients with end-stage HFrEF implanted with an LVAD. About Chronic Heart Failure Chronic heart failure (CHF) is characterized by poor heart function resulting in insufficient blood flow to the body's vital organs and extremities. This condition affects approximately 6.5 million people in the United States and 26 million people globally with increasing prevalence and incidence. Chronic heart failure patients are commonly classified according to the New York Heart Association (NYHA) categories based on the patient's physical limitations. Class I (mild) patients have no limitations while Class IV patients (severe/end stage) experience symptoms even at rest. The mortality rate approaches 50% at 5 years as patients progress beyond NYHA early class II disease in parallel with increasing inflammation in the heart and in the circulation. 3,4 Despite recent approvals of new therapies for HFrEF, NYHA class II/III HFrEF patients with inflammation remain at high risk for cardiovascular death, heart attacks and strokes. Over 100,000 patients annually in the US progress to end-stage heart failure (NYHA class IIIB/IV). These patients have a one-year mortality exceeding 50%. 5 Use of LVADs in end-stage heart failure patients to improve survival is gaining momentum, with approximately 2,000 LVADs implanted as destination therapy annually in the US, 6 the majority of whom have an ischemic etiology. About Mesoblast Mesoblast (the Company) is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates which respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant reduction of the damaging inflammatory process. Mesoblast has a strong and extensive global intellectual property portfolio with protection extending through to at least 2041 in all major markets. The Company's proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide. Mesoblast is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure and chronic low back pain. Two products have been commercialized in Japan and Europe by Mesoblast's licensees, and the Company has established commercial partnerships in Europe and China for certain Phase 3 assets. Mesoblast has locations in Australia, the United States and Singapore and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO). For more information, please see www.mesoblast.com , LinkedIn: Mesoblast Limited and Twitter: @Mesoblast References / Footnotes Perin EC. Et al. Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HF. Eur J Heart Fail 2024. https://doi.org/10.1002/ejhf.3522 Perin EC. Et al. Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients with Heart Failure. JACC Vol. 81, No. 9, 2023. https://doi.org/10.1016/j.jacc.2022.11.061 AHA's 2017 Heart Disease and Stroke Statistics Ponikowski P., et al. Heart Failure: Preventing disease and death worldwide. European Society of Cardiology . 2014; 1: 4-25 Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. European Journal of Heart Failure 2017;19:595-602. Yuzefpolskaya M et al. Ann Thorac Surg 2023; 115:311-28 Forward-Looking Statements This press release includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward-looking statements should not be read as a guarantee of future performance or results, and actual results may differ from the results anticipated in these forward-looking statements, and the differences may be material and adverse. Forward-looking statements include, but are not limited to, statements about: the initiation, timing, progress and results of Mesoblast's preclinical and clinical studies, and Mesoblast's research and development programs; Mesoblast's ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; Mesoblast's ability to advance its manufacturing capabilities; the timing or likelihood of regulatory filings and approvals (including any future decision that the FDA may make on the BLA for remestemcel-L for pediatric patients with SR-aGVHD), manufacturing activities and product marketing activities, if any; the commercialization of Mesoblast's product candidates, if approved; regulatory or public perceptions and market acceptance surrounding the use of stem-cell based therapies; the potential for Mesoblast's product candidates, if any are approved, to be withdrawn from the market due to patient adverse events or deaths; the potential benefits of strategic collaboration agreements and Mesoblast's ability to enter into and maintain established strategic collaborations; Mesoblast's ability to establish and maintain intellectual property on its product candidates and Mesoblast's ability to successfully defend these in cases of alleged infringement; the scope of protection Mesoblast is able to establish and maintain for intellectual property rights covering its product candidates and technology; estimates of Mesoblast's expenses, future revenues, capital requirements and its needs for additional financing; Mesoblast's financial performance; developments relating to Mesoblast's competitors and industry; and the pricing and reimbursement of Mesoblast's product candidates, if approved. You should read this press release together with our risk factors, in our most recently filed reports with the SEC or on our website. Uncertainties and risks that may cause Mesoblast's actual results, performance or achievements to be materially different from those which may be expressed or implied by such statements, and accordingly, you should not place undue reliance on these forward-looking statements. We do not undertake any obligations to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. Release authorized by the Chief Executive. For more information, please contact: Corporate Communications / Investors Media Paul Hughes BlueDot Media T: +61 3 9639 6036 Steve Dabkowski E: investors@mesoblast.com T: +61 419 880 486 E: steve@bluedot.net.au © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Craig 2-5 6-6 11, Goode 1-1 4-5 6, Millender 1-3 2-2 5, Walker 3-9 5-7 13, Zilinskas 11-20 5-5 32, Brown 3-7 4-4 11, Dudukovich 3-6 1-1 9, Garner 0-4 1-2 1, Rutland 0-2 0-0 0. Totals 24-57 28-32 88. Moodie 7-10 2-6 16, Bryant 3-5 10-11 17, Ford 6-12 7-8 20, Riley 3-11 0-0 9, Downey 1-5 0-0 2, Lee 2-4 1-1 5, Colon 0-2 0-0 0, Crosby 3-4 4-4 10, Smith 0-2 2-3 2, Greer 0-1 0-0 0, Abdur-Rahman 1-1 0-0 2, Kuir 0-0 0-0 0. Totals 26-57 26-33 83. Halftime_Alabama A&M 33-32. 3-Point Goals_IU Indianapolis 12-28 (Zilinskas 5-10, Dudukovich 2-4, Walker 2-5, Brown 1-2, Craig 1-3, Millender 1-3, Rutland 0-1), Alabama A&M 5-25 (Riley 3-11, Bryant 1-2, Ford 1-4, Lee 0-1, Smith 0-1, Colon 0-2, Downey 0-4). Fouled Out_Craig, Brown, Downey. Rebounds_IU Indianapolis 32 (Brown 8), Alabama A&M 32 (Ford 6). Assists_IU Indianapolis 11 (Walker 3), Alabama A&M 13 (Ford 7). Total Fouls_IU Indianapolis 23, Alabama A&M 26. A_320 (6,000).Justice & law enforcement at heart of SAD, Sikh polity crisisDeep-pocketed investors have adopted a bearish approach towards Riot Platforms RIOT , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in RIOT usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 19 extraordinary options activities for Riot Platforms. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 31% leaning bullish and 63% bearish. Among these notable options, 2 are puts, totaling $61,379, and 17 are calls, amounting to $841,100. Expected Price Movements Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $9.0 to $25.0 for Riot Platforms during the past quarter. Volume & Open Interest Development In terms of liquidity and interest, the mean open interest for Riot Platforms options trades today is 7584.62 with a total volume of 20,124.00. In the following chart, we are able to follow the development of volume and open interest of call and put options for Riot Platforms's big money trades within a strike price range of $9.0 to $25.0 over the last 30 days. Riot Platforms Option Volume And Open Interest Over Last 30 Days Biggest Options Spotted: Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume RIOT CALL TRADE BEARISH 01/16/26 $2.82 $2.8 $2.8 $20.00 $70.0K 16.1K 3.3K RIOT CALL TRADE BEARISH 01/16/26 $2.86 $2.8 $2.8 $20.00 $70.0K 16.1K 2.8K RIOT CALL TRADE BEARISH 01/16/26 $2.83 $2.8 $2.8 $20.00 $70.0K 16.1K 1.8K RIOT CALL TRADE BEARISH 01/16/26 $2.84 $2.8 $2.8 $20.00 $70.0K 16.1K 1.5K RIOT CALL TRADE BEARISH 01/16/26 $2.86 $2.8 $2.8 $20.00 $69.7K 16.1K 2.5K About Riot Platforms Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities. Following our analysis of the options activities associated with Riot Platforms, we pivot to a closer look at the company's own performance. Present Market Standing of Riot Platforms Currently trading with a volume of 18,478,271, the RIOT's price is up by 2.28%, now at $11.45. RSI readings suggest the stock is currently is currently neutral between overbought and oversold. Anticipated earnings release is in 62 days. Turn $1000 into $1270 in just 20 days? 20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access . Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely. If you want to stay updated on the latest options trades for Riot Platforms, Benzinga Pro gives you real-time options trades alerts. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The energy minister of Moldova is set to engage in pivotal discussions next week with the Russian gas company, Gazprom, in St. Petersburg. This meeting comes as an effort to ensure a continued and stable supply of electricity after Russian military actions have threatened energy networks in neighboring Ukraine. Moldova's reliance on its thermal power station, located in the Transdniestria region, is significant, with the plant being heavily dependent on gas supplies to function. This dependency is further complicated by Moldova's efforts to maintain its power grid in light of frequent Russian missile strikes on Ukraine's infrastructure. President Maia Sandu, aligning Moldova with pro-European stances, has condemned Russia's presence in Ukraine. Despite this political backdrop, logistical discussions with Russia are deemed necessary to secure the nation's energy future. (With inputs from agencies.)
New Delhi: External Affairs Minister (EAM) S Jaishankar and Kuwait’s Foreign Minister Abdullah Ali Al Yahya signed a Memorandum of Understanding (MoU) on Wednesday to establish a Joint Commission for Cooperation (JCC) at the level of foreign ministers. According to a press statement by the Ministry of External Affairs, the agreement outlines the formation of new Joint Working Groups in sectors including trade, investment, education, technology, agriculture, security, and culture, and these groups will operate under the JCC to review and monitor bilateral relations between the two nations. The JCC would also oversee existing working groups in areas such as hydrocarbons, health, and consular matters. “New Joint Working Groups in areas of Trade, Investment, Education, Technology, Agriculture, Security and Culture, will be set up under the JCC. The JCC mechanism will act as an umbrella institutional mechanism to comprehensively review and monitor the entire gamut of our bilateral relations under the new Joint Working Groups and the existing ones in areas including Hydrocarbons, Health and Consular matters,” the statement read. Abdullah Ali Al Yahya was on an official visit to India at the invitation of the EAM. This is the first official visit of Abdullah Ali Al Yahya as the foreign minister of Kuwait to India. During his visit, he met with Prime Minister Narendra Modi, who affirmed confidence in advancing the historical and deep-rooted ties between the two countries. Taking to X, PM Modi lauded the Kuwaiti leadership for ensuring the welfare of Indian nationals. “Glad to receive Foreign Minister of Kuwait H.E. Abdullah Ali Al-Yahya. I thank the Kuwaiti leadership for the welfare of the Indian nationals. India is committed to advancing our deep-rooted and historical ties for the benefit of our people and the region,” he stated on X. Kuwait’s Foreign Minister also held a bilateral meeting with the EAM, and during the bilateral meeting between them, the leaders reviewed the entire spectrum of India-Kuwait ties in areas including political, trade, investment, energy, food security, and people-to-people ties. They also exchanged views on regional and international issues of mutual interest, the Ministry of External Affairs noted in a press statement. During the bilateral meeting, Jaishankar congratulated Kuwait on its successful leadership of the Gulf Cooperation Council and also highlighted areas of cooperation between the two countries and thanked his counterpart for taking care of the Indian community in Kuwait. “Our two countries enjoy a long-standing friendship, and in our case, centuries old. We are committed to strengthening our bilateral ties across various domains, including trade, investment, energy, IT, culture, and consular,” he said. Kuwait Foreign Minister, Abdullah Ali Al-Yahya, during the meeting, called India a “very important partner,” adding that he looks forward to upgrading their bilateral relationship into a strategic partnership. He also expressed gratitude on meeting PM Modi and called him “one of the wisest people worldwide. The prime minister put India at a better level. And I’m sure he will continue for that.” This report is auto-generated from ANI news service. ThePrint holds no responsibility for its content. Also read: With Modi at the helm, India and the Arab world have become closer than ever. Here’s why var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );
QB Josh Allen and coach Sean McDermott deserve credit in Bills latest AFC East-clinching seasonHoneywell lowers sales, profit forecasts after Bombardier agreement